Author | Christopher Collins MD

Articles

My Favorite Report at ACR2014: Sifalimumab for Lupus

December 09, 2014

(ACR2014) Another Rheumatology Network Editorial Board member weighs in: Christopher Collins MD saw reason for great encouragement in a report about an interferon-α blocker for systemic lupus erythematosus.